Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

PW MEDTECH GROUP LIMITED

普 華 和 順 集 團 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1358)

POLL RESULTS OF

THE EXTRAORDINARY GENERAL MEETING

HELD ON NOVEMBER 7, 2019

The Board is pleased to announce that the resolution proposed at the EGM held on November 7, 2019 was duly passed.

The board of directors (the ''Board'') of PW Medtech Group Limited (the ''Company'') is pleased to announce that the resolution proposed at the extraordinary general meeting of the Company held on November 7, 2019 (the ''EGM'') was duly passed by way of poll. The poll results are as follows:

Number of Votes

Ordinary Resolution

(Approximate %) (Note (a))

For

Against

THAT:

996,371,363

13,277,550

(98.68%)

(1.32%)

(a) the share purchase agreement dated September 18, 2019 (the

''Share Purchase Agreement'') entered into between the

Company and Beachhead Holdings Limited, and the

transactions contemplated thereunder, be and are hereby

confirmed, approved and ratified; and

(b) the executive director of the Company be

and is hereby

authorized on behalf of the Company to do all such acts and

sign all such documents and to enter into all such

transactions and arrangements as may be necessary or

expedient in order to ensure smooth implementation of and

to give effect to the Share Purchase Agreement and the

transactions contemplated thereunder.

- 1 -

Notes:

  1. The number and percentage of votes are based on the total number of shares of the Company voted by the shareholders of the Company at the EGM in person or by proxy.
  2. As a majority of the votes were cast in favour of the resolution, such ordinary resolution was duly passed.
  3. The total number of shares of the Company in issue as at the date of the EGM: 1,569,246,098 shares.
  4. The total number of shares of the Company entitling the holder to attend and vote on the resolution at the EGM: 1,569,246,098 shares.
  5. The total number of shares of the Company for which the holders are entitled to attend but required to abstain from voting in favour of the resolution at the EGM as set out in Rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ''Listing Rules''): Nil.
  6. The total number of shares of the Company for which the holders are required under the Listing Rules to abstain from voting at the EGM: Nil.
  7. None of the shareholders of the Company have stated their intention in the Company's circular dated October 18, 2019 to vote against or to abstain from voting on the resolution at the EGM.
  8. The Company's branch share registrar in Hong Kong, Tricor Investor Services Limited, acted as the scrutineer for the vote-taking at the EGM.

By order of the Board

PW Medtech Group Limited

普華和順集團公司

Yue'e Zhang

Chairman & Chief Executive Officer

Hong Kong, November 7, 2019

As at the date of this announcement, the Board comprises one executive director, namely, Ms. Yue'e Zhang; two non- executive directors, namely Mr. Jiang Liwei and Mr. Lin Junshan; and three independent non-executive directors, namely, Mr. Wang Xiaogang, Mr. Zhang Xingdong and Mr. Chen Geng.

- 2 -

Attachments

  • Original document
  • Permalink

Disclaimer

PW Medtech Group Co. Ltd. published this content on 07 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 November 2019 08:59:04 UTC